Roberto Latagliata

28PUBLICATIONS
59CO-AUTHORS
Gene and molecular therapyHaematological tumoursMedical mycologyRespiratory diseasesCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (28)

|Aug 27, 2026
Sustained Erythroid Response to Eltrombopag in Low-Risk Myelodysplastic Neoplasms With Severe Anemia and Thrombocytopenia: A Case Report.

|Jul 22, 2026
Diabetic Patients With Newly Diagnosed Chronic Myeloid Leukemia: TKI Choice and Early Adverse Events. A Real-Life Survey Within the Italian Chronic Myeloid Leukemia Network.

|Mar 12, 2025
Spleen Involvement at Diagnosis of Multiple Myeloma: A Case Report and Literature Review.

Alessia Fiorini, Maria Gabriela Chavez, Valentina Panichi

|Jan 11, 2024
Safety and Efficacy of TKIs in very Elderly Patients (≥75 Years) with Chronic Myeloid Leukemia.

Alessandro Costa, Elisabetta Abruzzese, Roberto Latagliata

|Jul 29, 2023
Predictors of Response to Hydroxyurea and Switch to Ruxolitinib in HU-Resistant Polycythaemia VERA Patients: A Real-World PV-NET Study.

Francesca Palandri, Elena Rossi, Giuseppe Auteri

|Jun 24, 2023
Determinants of frontline tyrosine kinase inhibitor choice for patients with chronic-phase chronic myeloid leukemia: A study from the Registro Italiano LMC and Campus CML.

Mario Tiribelli, Roberto Latagliata, Massimo Breccia

Pageof 5

Frequent Collaborators

16 joint publications

Massimo Breccia

7 joint publications

Mario Tiribelli

7 joint publications

Massimiliano Bonifacio

7 joint publications

Giovanni Caocci